Zach Weinberg

Overview

An active angel investor with a strong track record in technology and healthcare sectors. Zach Weinberg is the Co-Founder and CEO of Curie.Bio, a founder-focused seed-stage venture firm combined with an industry-grade therapeutics accelerator. Prior to Curie.Bio, he co-founded Flatiron Health, a company acquired by Roche in 2018 for $2 billion, and Invite Media, acquired by Google in 2010 for $81 million. As an angel investor, he has invested in over 30 technology startups, including Bell Biosystems, Breakthrough.com, Care at Hand, DocPhin, Doctor Evidence, Genomera, Meddik, Oscar, and Predilytics. Zach studied economics and entrepreneurship at the Wharton School at the University of Pennsylvania. He also serves as an Advisor at Great Oaks Venture Capital. His investments span various sectors, including technology, healthcare, biotechnology, fintech, consumer goods, media, e-commerce, logistics, real estate, education, artificial intelligence, SaaS, cybersecurity, digital health, and food and beverage. His focus is on early-stage companies with innovative solutions and strong growth potential. Zach's investment philosophy centers on supporting visionary founders and companies that aim to make a significant impact in their respective industries. He leverages his extensive experience in building and scaling startups to provide strategic guidance and resources to portfolio companies, fostering their growth and success in competitive markets.

Investment Focus

• Innovative solutions
• Strong growth potential
• Visionary founders

Portfolio Companies